Cryogenic Solutions Inc. (CYGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Graham Marshman who wrote (3569)	4/22/1999 3:59:00 PM
From: James E Lynch	Read Replies (1) of 4028

(BSNS WIRE) Cryogenic Solutions Inc. Makes Announcement Cryogenic Solutions Inc. Makes Announcement Business Editors/Health & Medical Writers HOUSTON--(BUSINESS WIRE)--April 22, 1999--Cryogenic Solutions Inc. (OTC BB:CYGS) has begun shipping beta test kits of the company's proprietary ssDNA intracellular expression vector. So far, kits have been delivered to Yale University School of Medicine; Washington University in St Louis, Department of Cell Biology; and The Research Foundation of SUNY, Syracuse. The beta kits are ready for shipment to other investigators pending material transfer agreements from the universities and other research facilities. CYGS will soon be posting Requests for Proposals on its website, www.cygs.net. The RFP's will suggest a variety of studies the company wants to pursue in addition to the beta tests already scheduled and the primate studies beginning at the Southwest Foundation for Biological Research. The purpose of the in vivo studies is to demonstrate the ability of the ssDNA expression vector to synthesize any selected oligonucleotide sequence in the nuclei of a wide variety of targeted cell types. All proposals will be submitted to the CYGS Scientific Advisory Board for evaluation and approval. --30--EB/ho* CONTACT: Cryogenic Solutions Inc., Houston Dell Gibson, 713/780-1399 KEYWORD: TEXAS INDUSTRY KEYWORD: BIOTECHNOLOGY MEDICINE PHARMACEUTICAL Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: businesswire.com * end of story *

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next